Literature DB >> 15371741

Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain.

Xu Li1, Wen-Lin An, Irina Alafuzoff, Hilkka Soininen, Bengt Winblad, Jin-Jing Pei.   

Abstract

Eukaryotic translation factor 4E (eIF4E) plays a key role in regulating protein translation. It was thought that in order to maintain neuronal functions, tau protein is continuously generated to compensate those being hyperphosphorylated and compromised in its ability to promote and maintain microtubule assembly in Alzheimer's disease. If eIF4E is involved in tau mRNA translation, level of eIF4E phosphorylation should be changed. In the current study, we found a dramatic increase of phosphorylated eIF4E in Alzheimer's disease, especially in those cases with late stages of neurofibrillary changes. Level of eIF4E phosphorylation is significantly correlated with total- and Alzheimer hyperphosphorylated taus. These data suggest that the increase of eIF4E phosphorylation is involved in formation of Alzheimer neurofibrillary changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371741     DOI: 10.1097/00001756-200410050-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  25 in total

1.  Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Authors:  Paula Garcia-Esparcia; Georgios Sideris-Lampretsas; Karina Hernandez-Ortega; Oriol Grau-Rivera; Theodoros Sklaviadis; Ellen Gelpi; Isidro Ferrer
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

2.  mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.

Authors:  Han-Kyu Lee; Bumsup Kwon; Cynthia A Lemere; Suzanne de la Monte; Kyohei Itamura; Austin Y Ha; Henry W Querfurth
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.

Authors:  Sonja K Soo; Paige D Rudich; Annika Traa; Namasthée Harris-Gauthier; Hazel J Shields; Jeremy M Van Raamsdonk
Journal:  Mech Ageing Dev       Date:  2020-06-28       Impact factor: 5.432

4.  APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis.

Authors:  Sarayu Ramakrishna; Vishwaja Jhaveri; Sabine C Konings; Bharti Nawalpuri; Sumita Chakraborty; Bjørn Holst; Benjamin Schmid; Gunnar K Gouras; Kristine K Freude; Ravi S Muddashetty
Journal:  J Neurosci       Date:  2021-09-02       Impact factor: 6.167

Review 5.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

6.  Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.

Authors:  Michelle L Steinhilb; Dora Dias-Santagata; Tudor A Fulga; Daniel L Felch; Mel B Feany
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

Review 7.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

Review 8.  The role of mTOR signaling in Alzheimer disease.

Authors:  Salvatore Oddo
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

9.  Age-dependent shift in the de novo proteome accompanies pathogenesis in an Alzheimer's disease mouse model.

Authors:  Megan K Elder; Hediye Erdjument-Bromage; Mauricio M Oliveira; Maggie Mamcarz; Thomas A Neubert; Eric Klann
Journal:  Commun Biol       Date:  2021-06-30

Review 10.  Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.

Authors:  Henry Querfurth; Han-Kyu Lee
Journal:  Mol Neurodegener       Date:  2021-07-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.